New Hampshire Trust Purchases 116 Shares of UnitedHealth Group Incorporated $UNH

New Hampshire Trust increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 14.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 937 shares of the healthcare conglomerate’s stock after buying an additional 116 shares during the period. New Hampshire Trust’s holdings in UnitedHealth Group were worth $292,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. Prudent Man Advisors LLC grew its position in UnitedHealth Group by 34.2% during the 2nd quarter. Prudent Man Advisors LLC now owns 3,659 shares of the healthcare conglomerate’s stock worth $1,141,000 after purchasing an additional 932 shares during the last quarter. VestGen Investment Management raised its holdings in UnitedHealth Group by 17.0% during the second quarter. VestGen Investment Management now owns 723 shares of the healthcare conglomerate’s stock worth $226,000 after purchasing an additional 105 shares in the last quarter. University of Texas Texas AM Investment Management Co. increased its stake in UnitedHealth Group by 719.7% in the 2nd quarter. University of Texas Texas AM Investment Management Co. now owns 7,025 shares of the healthcare conglomerate’s stock valued at $2,192,000 after buying an additional 6,168 shares during the period. Interchange Capital Partners LLC raised its stake in UnitedHealth Group by 49.5% in the 2nd quarter. Interchange Capital Partners LLC now owns 6,611 shares of the healthcare conglomerate’s stock valued at $2,063,000 after purchasing an additional 2,190 shares during the last quarter. Finally, Linden Thomas Advisory Services LLC increased its position in UnitedHealth Group by 3.7% during the 2nd quarter. Linden Thomas Advisory Services LLC now owns 4,702 shares of the healthcare conglomerate’s stock worth $1,467,000 after purchasing an additional 168 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on UNH shares. Barclays lifted their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Piper Sandler cut their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Robert W. Baird reissued an “underperform” rating and issued a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Finally, Oppenheimer cut their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Eighteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $385.13.

UnitedHealth Group Stock Up 0.6%

UNH opened at $362.78 on Friday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The stock has a market capitalization of $328.56 billion, a P/E ratio of 15.72, a price-to-earnings-growth ratio of 2.35 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The business’s 50-day simple moving average is $338.43 and its 200-day simple moving average is $337.48.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the prior year, the business earned $6.80 earnings per share. The firm’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.4%. UnitedHealth Group’s payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.